Although the concentration of AraC used in our experiments is far from the therapeutic dose, we cannot exclude that the observed decrease in infection is related to greater cytotoxic effects of AraC, since the enhanced infection of DCs with HIV-C was accompanied by the highly phosphorylated status of SAMHD1 T592, leading to its inactivation [17]. Here, SAMHD1 is linked to infection.